New at-home spit test for prostate cancer could be better than blood test, study suggests

Single-cell and spatial RNA sequencing identify divergent microenvironments and progression signatures in early- versus late-onset prostate cancer

The clinical and pathological outcomes differ between early-onset (diagnosed in men ≤55 years of age) and late-onset prostate cancer, potentially attributed to the changes in hormone levels and immune activities associated with aging. Exploring the heterogeneity therein holds potential for developing age-specific precision interventions. Here, through single-cell and spatial transcriptomic analyses of prostate cancer tissues, we identified that …

Saliva Test Could Be Game Changer For Prostate Cancer Early Detection Say Scientists

What if a simple spit test could spot deadly prostate cancer before it has a chance to strike? UK scientists think they’re onto something big.Instead of waiting for symptoms or relying on the often-misleading PSA blood test, this new approach digs into your DNA. Researchers say a saliva sample can reveal 130 genetic mutations that quietly raise your odds of prostate cancer. And by flagging men most at risk, doctors can step in earlier with MRI s…

Prostate cancer: A new at-home saliva test beats blood test

Scientists writing in the New England Journal of Medicine said a genetic test using saliva is more accurate than a PSA blood test to assess prostate cancer risk.

At-home spit test could detect prostate cancer

A new at-home spit test for prostate cancer may be better than current testing methods, a new study has suggested.

At home prostate cancer test 'more effective' than current method

The simple test does not require a visit to the GP

New at-home spit test for prostate cancer could be better than blood test, study suggests

Experts have developed a simple saliva test which analyses genetic variants in a man's DNA which appears to perform better than the current method for assessing prostate cancer risk.